Deals
Deals dated after 30 September 2026 are still being collected.
Columns
4 of 4 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2026 | Corvex | – | Movano | Merger | Advisor to Corvex (target) | Completed | – | AI Infrastructure+2 | Chardan (sell-side)DLA Piper (sell-side)K&L Gates (buy-side)Goodwin (sell-side) | Movano and Corvex merger |
| Nov 2025 | Xanadu Quantum Technologies | – | Crane Harbor Acquisition Corp. | Merger | Financial adviser to Crane Harbor Acquisition Corp. (acquirer) | Pending | – | Deep Tech+1 | Houlihan Capital (buy-side)Morgan Stanley (sell-side)Cohen & Company Capital Markets (sell-side)Osler, Hoskin & Harcourt (sell-side)Cooley (sell-side)Winston Taylor (buy-side)Stevens & Lee (buy-side)Bennett Jones (buy-side) | Crane Harbor Acquisition Corp. and Xanadu Quantum Technologies merger |
| Nov 2025 | Xanadu Quantum Technologies | – | – | Placement | Placement agent to the lead managers | Pending | 275.0 | Deep Tech+1 | Morgan Stanley (lead manager)Cohen & Company Capital Markets (lead manager)CIBC Capital Markets (lead manager) | Xanadu Quantum Technologies placement |
| – | Vogenx | – | – | IPO | Bookrunner and underwriter | Announced | 81.3 | Biotech | Smith Anderson (issuer)Sichenzia Ross Ference Carmel (lead manager) | Vogenx IPO |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- Morgan Stanley
1 dealCompare - Cohen & Company Capital Markets1 dealCompare
- Osler, Hoskin & Harcourt
1 dealCompare - Cooley1 dealCompare
- K&L Gates
1 dealCompare
Firms advising the other side of the same deals.